SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

CORRESP Filing

Bionano Genomics, Inc.
Date: Sept. 11, 2025 · CIK: 0001411690 · Accession: 0001140361-25-034704

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-290187

Date
September 11, 2025
Author
H.C. WAINWRIGHT & CO., LLC
Form
CORRESP
Company
Bionano Genomics, Inc.

Letter

Re:

September 11, 2025

VIA EDGAR

U.S. Securities and Exchange Commission Division of Corporation Finance Washington, DC 20549

Bionano Genomics, Inc. Registration Statement on Form S-1 (File No. 333-290187) – Concurrence in Acceleration Request

Ladies and Gentlemen:

H.C. Wainwright & Co., LLC (“ Wainwright ”), solely acting as placement agent on a best efforts basis in an offering pursuant to the registration statement on Form S-1 (File No. 333-290187) (the “ Registration Statement ”), hereby concurs in the request by Bionano Genomics, Inc. that the effective date of the above-referenced registration statement be accelerated to 9:00 A.M (Eastern Time), or as soon as practicable thereafter, on September 15, 2025, pursuant to Rule 461 under the Securities Act of 1933, as amended (the “ Securities Act ”). Wainwright affirms that it is aware of its obligations under the Securities Act as they pertain to the best efforts offering pursuant to the Registration Statement.

Very truly yours,
H.C. WAINWRIGHT & CO., LLC

Show Raw Text
CORRESP
 1
 filename1.htm

 September 11, 2025

 VIA EDGAR

 U.S. Securities and Exchange Commission
 Division of Corporation Finance
 Washington, DC 20549

 Re:

 Bionano Genomics, Inc.
 Registration Statement on Form S-1 (File No. 333-290187) – Concurrence in Acceleration Request

 Ladies and Gentlemen:

 H.C. Wainwright & Co., LLC (“ Wainwright ”),
 solely acting as placement agent on a best efforts basis in an offering pursuant to the registration statement on Form S-1 (File No. 333-290187) (the “ Registration
 Statement ”), hereby concurs in the request by Bionano Genomics, Inc. that the effective date of the above-referenced registration statement be accelerated to 9:00 A.M (Eastern Time), or as soon as practicable thereafter, on September
 15, 2025, pursuant to Rule 461 under the Securities Act of 1933, as amended (the “ Securities Act ”). Wainwright affirms that it is aware of its obligations
 under the Securities Act as they pertain to the best efforts offering pursuant to the Registration Statement.

 Very truly yours,

 H.C. WAINWRIGHT & CO., LLC

 By:

 /s/ Edward. D. Silvera

 Name: Edward D. Silvera

 Title: Chief Operating Officer